Literature DB >> 19145463

Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

Sandip Hindocha1, Duncan Angus McGrouther, Ardeshir Bayat.   

Abstract

Dupuytren's Disease (DD) is a common, fibroproliferative disorder affecting the palmar surface of the hands which is often irreversible and progressive. Understanding the epidemiology of DD is important in order to provide clues to its etiopathogenesis. This review aims to evaluate the epidemiological studies carried out in DD since 1951. Studies evaluating the epidemiology of DD were searched using Medline, Pubmed, and Scopus which dated back from 1951 to current date. Inclusion criteria were any studies investigating the prevalence or incidence of DD in any population group. A total of 620 articles were cited. Forty-nine studies were subsequently identified as relevant to evaluating the epidemiology of DD. The prevalence of DD in all studies increased with age with a male to female ratio of approximately 5.9:1. Prevalence rates ranged from 0.2% to 56% in varying age, population groups, and methods of data collection. The highest prevalence rate was reported in a study group of epileptic patients. Although, only one study calculated the incidence (as opposed to prevalence) of DD to be equal to 34.3 per 100,000 men (0.03%). In conclusion, the prevalence of DD in different geographical locations is extremely variable, and it is not clear whether this is genetic, environmental, or a combination of both. The majority of the prevalence studies have been conducted in Scandinavia or the UK, and the vast changes in population structure, the changes in prevalence of associated diseases, and the change in diagnostic criteria of DD makes understanding the epidemiology of this condition difficult.

Entities:  

Year:  2009        PMID: 19145463      PMCID: PMC2724613          DOI: 10.1007/s11552-008-9160-9

Source DB:  PubMed          Journal:  Hand (N Y)        ISSN: 1558-9447


  99 in total

1.  Dupuytren's disease in type 1 diabetic patients: a five-year prospective study.

Authors:  P E Arkkila; I M Kantola; J S Viikari; T Rönnemaa; M A Vähätalo
Journal:  Clin Exp Rheumatol       Date:  1996 Jan-Feb       Impact factor: 4.473

2.  The association between alcohol, hepatic pathology and Dupuytren's disease.

Authors:  J Noble; M Arafa; S G Royle; G McGeorge; S Crank
Journal:  J Hand Surg Br       Date:  1992-02

3.  The prevalence of Dupuytren's disease among 2 different ethnic groups in northern Norway.

Authors:  Vilhjalmur Finsen; Henrik Dalen; Julie Nesheim
Journal:  J Hand Surg Am       Date:  2002-01       Impact factor: 2.230

4.  Dupuytren's contractures in a black patient in East Africa.

Authors:  D W Furnas
Journal:  Plast Reconstr Surg       Date:  1979-08       Impact factor: 4.730

Review 5.  Dupuytren's disease in blacks.

Authors:  M V Makhlouf; E B Cabbabe; R E Shively
Journal:  Ann Plast Surg       Date:  1987-10       Impact factor: 1.539

6.  Dupuytren's disease in identical twins.

Authors:  H A Lyall
Journal:  J Hand Surg Br       Date:  1993-06

7.  The hand complications of Colles' fractures.

Authors:  H D Stewart; A R Innes; F D Burke
Journal:  J Hand Surg Br       Date:  1985-02

8.  [Dupuytren's contracture: review of the literature. Case report of a black African].

Authors:  M Richard-Kadio; F Guedegbe; R Dick; E Keli; P Yapo; E Malan; H A N'Guessan; L Cornet
Journal:  Med Trop (Mars)       Date:  1990 Jul-Sep

9.  A prospective study linked both alcohol and tobacco to Dupuytren's disease.

Authors:  Nina S Godtfredsen; Hasse Lucht; Eva Prescott; Thorkild I A Sørensen; Morten Grønbaek
Journal:  J Clin Epidemiol       Date:  2004-08       Impact factor: 6.437

10.  Dupuytren's disease in Bosnia and Herzegovina. An epidemiological study.

Authors:  Dragan Zerajic; Vilhjalmur Finsen
Journal:  BMC Musculoskelet Disord       Date:  2004-03-29       Impact factor: 2.362

View more
  50 in total

1.  Heavy manual work, exposure to vibration and Dupuytren's disease? Results of a surveillance program for musculoskeletal disorders.

Authors:  Alexis Descatha; Julie Bodin; Catherine Ha; Pierre Goubault; Marine Lebreton; Jean François Chastang; Ellen Imbernon; Annette Leclerc; Marcel Goldberg; Yves Roquelaure
Journal:  Occup Environ Med       Date:  2012-01-02       Impact factor: 4.402

Review 2.  [Epidemiology of Dupuytren's disease].

Authors:  P Hahn
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

Review 3.  [Percutaneous needle aponeurotomy for Dupuytren's contracture].

Authors:  J Oppermann; F Unglaub; L P Müller; S Löw; P Hahn; C K Spies
Journal:  Orthopade       Date:  2017-04       Impact factor: 1.087

4.  Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren's disease: a potential source of myofibroblasts with implications for pathogenesis and therapy.

Authors:  Syed Amir Iqbal; Christopher Manning; Farhatullah Syed; Venkatesh Kolluru; Mike Hayton; Stewart Watson; Ardeshir Bayat
Journal:  Stem Cells Dev       Date:  2011-07-19       Impact factor: 3.272

Review 5.  Collagenase clostridium histolyticum in Dupuytren's contracture: a systematic review.

Authors:  Francesco Smeraglia; Angelo Del Buono; Nicola Maffulli
Journal:  Br Med Bull       Date:  2016-05-05       Impact factor: 4.291

6.  The Baron's complaint.

Authors:  Mark A Jobling
Journal:  Investig Genet       Date:  2011-08-18

7.  Proposal for Treatment of Severe Dupuytren Disease in 2 Steps: Progressive Distraction With External Fixator and Collagenase - A Preliminary Case Series.

Authors:  Massimo Corain; Filippo Zanotti; Roberta Sartore; Paolo Pozza
Journal:  Hand (N Y)       Date:  2019-02-22

8.  Dupuytren's fibroblast contractility by sphingosine-1-phosphate is mediated through non-muscle myosin II.

Authors:  Issei Komatsu; Jennifer Bond; Angelica Selim; James J Tomasek; L Scott Levin; Howard Levinson
Journal:  J Hand Surg Am       Date:  2010-10       Impact factor: 2.230

Review 9.  Scientific understanding and clinical management of Dupuytren disease.

Authors:  Barbara Shih; Ardeshir Bayat
Journal:  Nat Rev Rheumatol       Date:  2010-11-09       Impact factor: 20.543

10.  Metabolic factors and the risk of Dupuytren's disease: data from 30,000 individuals followed for over 20 years.

Authors:  Mattias Rydberg; Malin Zimmerman; Jin Persson Löfgren; Anders Gottsäter; Peter M Nilsson; Olle Melander; Lars B Dahlin
Journal:  Sci Rep       Date:  2021-07-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.